Dysregulated expression of homeobox family genes may influence survival outcomes of patients with epithelial ovarian cancer

Analysis of data from the cancer genome atlas

Kyung Jin Eoh, Hee Jung Kim, Jung Yun Lee, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, YoungTae Kim

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Homeobox (HOX) family genes encode key transcription factors for embryogenesis and may be correlated with carcinogenesis. The aim of this study was to elucidate whether aberrant expression of HOX genes influences outcomes in epithelial ovarian cancer (EOC). Gene expression data and clinicopathologic information from 630 patients with EOC were downloaded from The Cancer Genome Atlas database. We explored correlations between expression levels of HOX gene family members and clinicopathological variables. Higher expression of HOXA1, A4, A5, A7, A10, A11, B13, C13, D1, and D3 was associated with advanced FIGO stage. Suboptimal residual disease after debulking surgery was significantly correlated with higher expression of HOXB9, B13, and C13. Additionally, patients with high expression of HOXC6 and C11 were significantly more likely to have poor performance status. Overall survival was significantly shorter in patients with high, rather than low, expression of two HOX genes (HOXA10 and B3), and significantly longer in patients with high rather than low HOXC5 expression. Dysregulated expression of the HOXA10, B3, and C5 was significantly correlated with overall survival in EOC patients. HOX gene expression levels are potentially useful as a prognostic indicator in EOC, and HOX genes may represent a novel and promising target for anticancer therapeutics.

Original languageEnglish
Pages (from-to)70579-70585
Number of pages7
JournalOncotarget
Volume8
Issue number41
DOIs
Publication statusPublished - 2017 Jan 1

Fingerprint

Atlases
Homeobox Genes
Genome
Survival
Neoplasms
Gene Expression
Neoplasm Genes
antineoplaston A10
Embryonic Development
Ovarian epithelial cancer
Carcinogenesis
Transcription Factors
Databases

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Eoh, Kyung Jin ; Kim, Hee Jung ; Lee, Jung Yun ; Nam, Eun Ji ; Kim, Sunghoon ; Kim, Sang Wun ; Kim, YoungTae. / Dysregulated expression of homeobox family genes may influence survival outcomes of patients with epithelial ovarian cancer : Analysis of data from the cancer genome atlas. In: Oncotarget. 2017 ; Vol. 8, No. 41. pp. 70579-70585.
@article{b191633ba78d41aaa2ed883edcd06bbc,
title = "Dysregulated expression of homeobox family genes may influence survival outcomes of patients with epithelial ovarian cancer: Analysis of data from the cancer genome atlas",
abstract = "Homeobox (HOX) family genes encode key transcription factors for embryogenesis and may be correlated with carcinogenesis. The aim of this study was to elucidate whether aberrant expression of HOX genes influences outcomes in epithelial ovarian cancer (EOC). Gene expression data and clinicopathologic information from 630 patients with EOC were downloaded from The Cancer Genome Atlas database. We explored correlations between expression levels of HOX gene family members and clinicopathological variables. Higher expression of HOXA1, A4, A5, A7, A10, A11, B13, C13, D1, and D3 was associated with advanced FIGO stage. Suboptimal residual disease after debulking surgery was significantly correlated with higher expression of HOXB9, B13, and C13. Additionally, patients with high expression of HOXC6 and C11 were significantly more likely to have poor performance status. Overall survival was significantly shorter in patients with high, rather than low, expression of two HOX genes (HOXA10 and B3), and significantly longer in patients with high rather than low HOXC5 expression. Dysregulated expression of the HOXA10, B3, and C5 was significantly correlated with overall survival in EOC patients. HOX gene expression levels are potentially useful as a prognostic indicator in EOC, and HOX genes may represent a novel and promising target for anticancer therapeutics.",
author = "Eoh, {Kyung Jin} and Kim, {Hee Jung} and Lee, {Jung Yun} and Nam, {Eun Ji} and Sunghoon Kim and Kim, {Sang Wun} and YoungTae Kim",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.19771",
language = "English",
volume = "8",
pages = "70579--70585",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "41",

}

Dysregulated expression of homeobox family genes may influence survival outcomes of patients with epithelial ovarian cancer : Analysis of data from the cancer genome atlas. / Eoh, Kyung Jin; Kim, Hee Jung; Lee, Jung Yun; Nam, Eun Ji; Kim, Sunghoon; Kim, Sang Wun; Kim, YoungTae.

In: Oncotarget, Vol. 8, No. 41, 01.01.2017, p. 70579-70585.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dysregulated expression of homeobox family genes may influence survival outcomes of patients with epithelial ovarian cancer

T2 - Analysis of data from the cancer genome atlas

AU - Eoh, Kyung Jin

AU - Kim, Hee Jung

AU - Lee, Jung Yun

AU - Nam, Eun Ji

AU - Kim, Sunghoon

AU - Kim, Sang Wun

AU - Kim, YoungTae

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Homeobox (HOX) family genes encode key transcription factors for embryogenesis and may be correlated with carcinogenesis. The aim of this study was to elucidate whether aberrant expression of HOX genes influences outcomes in epithelial ovarian cancer (EOC). Gene expression data and clinicopathologic information from 630 patients with EOC were downloaded from The Cancer Genome Atlas database. We explored correlations between expression levels of HOX gene family members and clinicopathological variables. Higher expression of HOXA1, A4, A5, A7, A10, A11, B13, C13, D1, and D3 was associated with advanced FIGO stage. Suboptimal residual disease after debulking surgery was significantly correlated with higher expression of HOXB9, B13, and C13. Additionally, patients with high expression of HOXC6 and C11 were significantly more likely to have poor performance status. Overall survival was significantly shorter in patients with high, rather than low, expression of two HOX genes (HOXA10 and B3), and significantly longer in patients with high rather than low HOXC5 expression. Dysregulated expression of the HOXA10, B3, and C5 was significantly correlated with overall survival in EOC patients. HOX gene expression levels are potentially useful as a prognostic indicator in EOC, and HOX genes may represent a novel and promising target for anticancer therapeutics.

AB - Homeobox (HOX) family genes encode key transcription factors for embryogenesis and may be correlated with carcinogenesis. The aim of this study was to elucidate whether aberrant expression of HOX genes influences outcomes in epithelial ovarian cancer (EOC). Gene expression data and clinicopathologic information from 630 patients with EOC were downloaded from The Cancer Genome Atlas database. We explored correlations between expression levels of HOX gene family members and clinicopathological variables. Higher expression of HOXA1, A4, A5, A7, A10, A11, B13, C13, D1, and D3 was associated with advanced FIGO stage. Suboptimal residual disease after debulking surgery was significantly correlated with higher expression of HOXB9, B13, and C13. Additionally, patients with high expression of HOXC6 and C11 were significantly more likely to have poor performance status. Overall survival was significantly shorter in patients with high, rather than low, expression of two HOX genes (HOXA10 and B3), and significantly longer in patients with high rather than low HOXC5 expression. Dysregulated expression of the HOXA10, B3, and C5 was significantly correlated with overall survival in EOC patients. HOX gene expression levels are potentially useful as a prognostic indicator in EOC, and HOX genes may represent a novel and promising target for anticancer therapeutics.

UR - http://www.scopus.com/inward/record.url?scp=85030249039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030249039&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.19771

DO - 10.18632/oncotarget.19771

M3 - Article

VL - 8

SP - 70579

EP - 70585

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 41

ER -